Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.270
+0.040 (3.25%)
May 19, 2026, 4:00 PM EDT - Market closed

Entera Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2018
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '18
Cash & Equivalents
4.147.118.6611.0212.317.51
Short-Term Investments
-----4.02
Cash & Short-Term Investments
4.147.118.6611.0212.3111.52
Cash Growth
-67.10%-17.92%-21.41%-10.48%6.84%-1.92%
Accounts Receivable
--0.13-0.250.73
Other Current Assets
8.368.190.190.240.290.22
Total Current Assets
12.4915.38.9711.2612.8512.47
Net Property, Plant & Equipment
0.540.60.330.490.230.22
Other Intangible Assets
-----0.65
Other Long-Term Assets
0.10.10.090.020.05-
Total Assets
13.1315.999.3911.7713.1313.34
Accounts Payable
0.270.450.130.080.02-
Accrued Expenses
1.121.530.870.871.23-
Current Portion of Leases
0.190.230.170.130.09-
Unearned Revenue
-----0.23
Total Current Liabilities
1.582.21.181.091.341.79
Long-Term Leases
0.260.260.10.26--
Other Long-Term Liabilities
0.60.430.030.030.031.44
Total Long-Term Liabilities
0.870.690.130.290.031.44
Total Liabilities
2.442.891.311.381.373.23
Common Stock
0000--
Additional Paid-in Capital
139.52138.43121.97114.73107.2149.17
Accumulated Other Comprehensive Income
0.040.040.040.040.0413.06
Retained Earnings
-128.87-125.37-113.93-104.39-95.5-52.12
Shareholders' Equity
10.6913.18.0810.3911.7510.12
Total Liabilities & Equity
13.1315.999.3911.7713.1313.34
Total Debt
0.450.490.270.390.090
Net Cash (Debt)
3.696.628.3910.6312.2211.52
Net Cash Growth
-44.26%-21.10%-21.08%-13.00%6.05%46.71%
Net Cash Per Share
0.080.140.220.370.421.44
Book Value
10.6913.18.0810.3911.7510.12
Book Value Per Share
0.230.280.210.360.411.27
Tangible Book Value
10.6913.18.0810.3911.759.47
Tangible Book Value Per Share
0.230.280.210.360.411.19
Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q